chr13-34942868-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001385012.1(NBEA):āc.48C>Gā(p.Pro16=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000561 in 1,409,702 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0029 ( 2 hom., cov: 31)
Exomes š: 0.00029 ( 0 hom. )
Consequence
NBEA
NM_001385012.1 synonymous
NM_001385012.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.375
Genes affected
NBEA (HGNC:7648): (neurobeachin) This gene encodes a member of a large, diverse group of A-kinase anchor proteins that target the activity of protein kinase A to specific subcellular sites by binding to its type II regulatory subunits. Brain-specific expression and coat protein-like membrane recruitment of a highly similar protein in mouse suggest an involvement in neuronal post-Golgi membrane traffic. Mutations in this gene may be associated with a form of autism. This gene and its expression are frequently disrupted in patients with multiple myeloma. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants may exist, but their full-length nature has not been determined.[provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 13-34942868-C-G is Benign according to our data. Variant chr13-34942868-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 790672.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-34942868-C-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.375 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00288 (432/150176) while in subpopulation AFR AF= 0.00994 (407/40966). AF 95% confidence interval is 0.00914. There are 2 homozygotes in gnomad4. There are 199 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 432 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NBEA | NM_001385012.1 | c.48C>G | p.Pro16= | synonymous_variant | 1/59 | ENST00000379939.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NBEA | ENST00000379939.7 | c.48C>G | p.Pro16= | synonymous_variant | 1/59 | 5 | NM_001385012.1 |
Frequencies
GnomAD3 genomes AF: 0.00289 AC: 433AN: 150068Hom.: 2 Cov.: 31
GnomAD3 genomes
AF:
AC:
433
AN:
150068
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000295 AC: 16AN: 54276Hom.: 0 AF XY: 0.000243 AC XY: 7AN XY: 28804
GnomAD3 exomes
AF:
AC:
16
AN:
54276
Hom.:
AF XY:
AC XY:
7
AN XY:
28804
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000285 AC: 359AN: 1259526Hom.: 0 Cov.: 24 AF XY: 0.000244 AC XY: 150AN XY: 614886
GnomAD4 exome
AF:
AC:
359
AN:
1259526
Hom.:
Cov.:
24
AF XY:
AC XY:
150
AN XY:
614886
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00288 AC: 432AN: 150176Hom.: 2 Cov.: 31 AF XY: 0.00271 AC XY: 199AN XY: 73342
GnomAD4 genome
AF:
AC:
432
AN:
150176
Hom.:
Cov.:
31
AF XY:
AC XY:
199
AN XY:
73342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 13, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | NBEA: BP4, BP7, BS1 - |
NBEA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at